These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
664 related articles for article (PubMed ID: 26711836)
21. Clinical characteristics, pathological reevaluation, surgical management and adjuvant therapy of patients with endometrial stromal tumors. Rothmund R; Hartkopf A; Joachim C; Walter CB; Wallwiener M; Kraemer B; Brucker SY; Staebler A; Taran FA Arch Gynecol Obstet; 2014 Dec; 290(6):1195-200. PubMed ID: 24981048 [TBL] [Abstract][Full Text] [Related]
22. Uterine sarcoma: twenty-seven years of experience. Livi L; Paiar F; Shah N; Blake P; Villanucci A; Amunni G; Barca R; Judson I; Lodge N; Meldolesi E; Simontacchi G; Piperno G; Galardi A; Scoccianti S; Biti GP; Harmer C Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1366-73. PubMed ID: 14630275 [TBL] [Abstract][Full Text] [Related]
23. Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988-2007. Gao Y; Meng H; Zhang Y; Jiao T; Hui N Int J Clin Exp Pathol; 2014; 7(4):1616-24. PubMed ID: 24817958 [TBL] [Abstract][Full Text] [Related]
24. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study. Seagle BL; Shilpi A; Buchanan S; Goodman C; Shahabi S Gynecol Oncol; 2017 Aug; 146(2):254-262. PubMed ID: 28596015 [TBL] [Abstract][Full Text] [Related]
25. A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China. Li D; Yin N; Du G; Wang S; Xiao Z; Chen J; Chen W Int J Biol Sci; 2020; 16(3):388-395. PubMed ID: 32015676 [TBL] [Abstract][Full Text] [Related]
26. Malignant mixed müllerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival. George E; Lillemoe TJ; Twiggs LB; Perrone T Int J Gynecol Pathol; 1995 Jan; 14(1):39-44. PubMed ID: 7883424 [TBL] [Abstract][Full Text] [Related]
27. Systemic treatment in adult uterine sarcomas. Desar IME; Ottevanger PB; Benson C; van der Graaf WTA Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779 [TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study. Wang F; Dai X; Chen H; Hu X; Wang Y BMC Cancer; 2022 Oct; 22(1):1050. PubMed ID: 36207687 [TBL] [Abstract][Full Text] [Related]
29. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435 [TBL] [Abstract][Full Text] [Related]
30. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas. Wolfson AH; Wolfson DJ; Sittler SY; Breton L; Markoe AM; Schwade JG; Houdek PV; Averette HE; Sevin BU; Penalver M Gynecol Oncol; 1994 Jan; 52(1):56-62. PubMed ID: 8307502 [TBL] [Abstract][Full Text] [Related]
31. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma. Giuntoli RL; Lessard-Anderson CR; Gerardi MA; Kushnir CL; Cliby WA; Metzinger DS; Gostout BS Int J Gynecol Cancer; 2013 Jun; 23(5):869-76. PubMed ID: 23669444 [TBL] [Abstract][Full Text] [Related]
32. Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma. Davidson B; Hellesylt E; Holth A; Danielsen HE; Skeie-Jensen T; Katz B Virchows Arch; 2017 Sep; 471(3):355-362. PubMed ID: 28643014 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers. Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A Tumour Biol; 2011 Jun; 32(3):451-9. PubMed ID: 21161468 [TBL] [Abstract][Full Text] [Related]
34. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough? Feng W; Hua K; Malpica A; Zhou X; Baak JP Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438 [TBL] [Abstract][Full Text] [Related]
35. [A clinical analysis of 153 uterine sarcomas]. Bai P; Sun J; Chao H Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892 [TBL] [Abstract][Full Text] [Related]
36. Prognostic factors, oncological treatment and outcomes of uterine sarcoma: 10 years' clinical experience from a tertiary care center in Pakistan. Khan SR; Soomar SM; Asghari T; Ahmed A; Moosajee MS BMC Cancer; 2023 Jun; 23(1):510. PubMed ID: 37277708 [TBL] [Abstract][Full Text] [Related]
37. Recent advances in the treatment of sarcomas in gynecology. Lange SS; Novetsky AP; Powell MA Discov Med; 2014 Sep; 18(98):133-40. PubMed ID: 25227754 [TBL] [Abstract][Full Text] [Related]
38. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group. Meurer M; Floquet A; Ray-Coquard I; Bertucci F; Auriche M; Cordoba A; Piperno-Neumann S; Salas S; Delannes M; Chevalier T; Italiano A; Blay JY; Mancini J; Pautier P; Duffaud F Int J Gynecol Cancer; 2019 May; 29(4):691-698. PubMed ID: 30772825 [TBL] [Abstract][Full Text] [Related]
39. [Clinicopathologic features and prognostic factors of endometrial stromal sarcoma: a study of 55 cases]. Shi JL; Cheng NH; Guo LN; Lian LJ Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):517-22. PubMed ID: 22169638 [TBL] [Abstract][Full Text] [Related]
40. Cervical and peritoneal fluid cytology of uterine sarcomas. Wang X; Khoo US; Xue WC; Cheung AN Acta Cytol; 2002; 46(3):465-9. PubMed ID: 12040638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]